{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:00:54Z","timestamp":1791291654427,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,4,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Today it is generally accepted that B cells require cognate interactions with CD4+ T cells to develop high-affinity antibodies against proteins. CD4+ T cells recognize peptides (epitopes) presented by MHC class II molecules that are expressed on antigen-presenting cells. Structural features of both the MHC class II molecule and the peptide determine the specificity of CD4+ T cells that can bind to the MHC class II\u2013peptide complex. We used a new humanized hemophilic mouse model to identify FVIII peptides presented by HLA-DRB1*1501. This model carries a knockout of all murine MHC class II molecules and expresses a chimeric murine-human MHC class II complex that contains the peptide-binding sites of the human HLA-DRB1*1501. When mice were treated with human FVIII, the proportion of mice that developed antibodies depended on the application route of FVIII and the activation state of the innate immune system. We identified 8 FVIII peptide regions that contained CD4+ T-cell epitopes presented by HLA-DRB1*1501 to CD4+ T cells during immune responses against FVIII. CD4+ T-cell responses after intravenous and subcutaneous application of FVIII involved the same immunodominant FVIII epitopes. Interestingly, most of the 8 peptide regions contained promiscuous epitopes that bound to several different HLA-DR proteins in in vitro binding assays.<\/jats:p>","DOI":"10.1182\/blood-2011-08-374645","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T06:31:31Z","timestamp":1331101891000},"page":"4073-4082","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":70,"title":["CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice"],"prefix":"10.1182","volume":"119","author":[{"given":"Katharina N.","family":"Steinitz","sequence":"first","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline M.","family":"van Helden","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Binder","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wraith","sequence":"additional","affiliation":[{"name":"University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Unterthurner","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Hermann","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Schuster","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi U.","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Weiller","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lubich","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurus","family":"de la Rosa","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit M.","family":"Reipert","sequence":"additional","affiliation":[{"name":"Baxter BioScience, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111807384156900_B1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4613-0331-2_3","article-title":"The incidence of factor VIII inhibitors in patients with severe hemophilia A.","volume-title":"Inhibitors to Coagulation Factors","author":"Hoyer","year":"1995"},{"key":"2019111807384156900_B2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2006.01361.x","article-title":"Genetic risk factors for inhibitors to factors VIII and IX.","volume":"12","author":"Oldenburg","year":"2006","journal-title":"Haemophilia"},{"issue":"11","key":"2019111807384156900_B3","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1182\/blood-2006-11-056291","article-title":"Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study.","volume":"109","author":"Gouw","year":"2007","journal-title":"Blood"},{"issue":"6585","key":"2019111807384156900_B4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","article-title":"Clonal selection and learning in the antibody system.","volume":"381","author":"Rajewsky","year":"1996","journal-title":"Nature"},{"issue":"11","key":"2019111807384156900_B5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nri1714","article-title":"Follicular B helper T cells in antibody responses and autoimmunity.","volume":"5","author":"Vinuesa","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2019111807384156900_B6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1537-2995.1989.29589284147.x","article-title":"Disappearance of inhibitor to factor VIII in HIV-infected hemophiliacs with progression to AIDS or severe ARC.","volume":"29","author":"Ragni","year":"1989","journal-title":"Transfusion"},{"issue":"2","key":"2019111807384156900_B7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0037-1612983","article-title":"Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.","volume":"87","author":"Sasgary","year":"2002","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111807384156900_B8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0952-7915(94)90033-7","article-title":"Defining rules for the peptide-MHC class II interaction.","volume":"6","author":"Sinigaglia","year":"1994","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2019111807384156900_B9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coi.2005.11.002","article-title":"The wide diversity and complexity of peptides bound to class II MHC molecules.","volume":"18","author":"Suri","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"6673","key":"2019111807384156900_B10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity.","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"2","key":"2019111807384156900_B11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12016-009-8120-7","article-title":"B-cell and T-cell epitopes in anti\u2013factor VIII immune responses.","volume":"37","author":"Pratt","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"2019111807384156900_B12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1538-7836.2004.00918.x","article-title":"T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.","volume":"2","author":"Hu","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111807384156900_B13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1538-7836.2004.00850.x","article-title":"Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII.","volume":"2","author":"Reding","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111807384156900_B14","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1046\/j.1538-7836.2003.00251.x","article-title":"Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII.","volume":"1","author":"Reding","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111807384156900_B15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood-2002-05-1369","article-title":"CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild\/moderate hemophilia A.","volume":"101","author":"Jacquemin","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2019111807384156900_B16","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/j.1538-7836.2007.02762.x","article-title":"T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111807384156900_B17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1538-7836.2011.04202.x","article-title":"T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site.","volume":"9","author":"James","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111807384156900_B18","doi-asserted-by":"crossref","first-page":"M110.002246","DOI":"10.1074\/mcp.M110.002246","article-title":"HLA-DR-presented peptide-repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.","volume":"10","author":"van Haren","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"2019111807384156900_B19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1538-7836.2009.03403.x","article-title":"Opportunities and limitations of mouse models humanized for HLA class II antigens.","volume":"7","author":"Reipert","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111807384156900_B20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1655944","article-title":"HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A: UKHCDO Inhibitor Working Party.","volume":"77","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"issue":"2","key":"2019111807384156900_B21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1655945","article-title":"HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII.","volume":"77","author":"Oldenburg","year":"1997","journal-title":"Thromb Haemost"},{"issue":"12","key":"2019111807384156900_B22","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A.","volume":"7","author":"Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111807384156900_B23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.180.1.173","article-title":"Human major histocompatibility complex class II-restricted T cell responses in transgenic mice.","volume":"180","author":"Woods","year":"1994","journal-title":"J Exp Med"},{"issue":"1","key":"2019111807384156900_B24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"issue":"4","key":"2019111807384156900_B25","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1055\/s-0037-1614401","article-title":"Phenotypic expression of murine hemophilia.","volume":"82","author":"Muchitsch","year":"1999","journal-title":"Thromb Haemost"},{"issue":"5","key":"2019111807384156900_B26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-0037-1613094","article-title":"Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.","volume":"87","author":"Hausl","year":"2002","journal-title":"Thromb Haemost"},{"issue":"10","key":"2019111807384156900_B27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1292","article-title":"Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.","volume":"11","author":"Frentsch","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"2019111807384156900_B28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/blood-2003-07-2456","article-title":"Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders.","volume":"104","author":"Hausl","year":"2004","journal-title":"Blood"},{"key":"2019111807384156900_B29","article-title":"Production of mouse T cell hybridomas.","author":"Kruisbeek","year":"2001","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"2019111807384156900_B30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/bip.20637","article-title":"Sorting and pooling strategy: a novel tool to map a virus proteome for CD8 T-cell epitopes.","volume":"88","author":"Ay","year":"2007","journal-title":"Biopolymers"},{"issue":"9","key":"2019111807384156900_B31","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.4049\/jimmunol.157.9.3850","article-title":"Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.","volume":"157","author":"Pickl","year":"1996","journal-title":"J Immunol"},{"issue":"9","key":"2019111807384156900_B32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20021074","article-title":"Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire.","volume":"196","author":"Pasqual","year":"2002","journal-title":"J Exp Med"},{"issue":"12","key":"2019111807384156900_B33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nri2669","article-title":"Antigen presentation in the thymus for positive selection and central tolerance induction.","volume":"9","author":"Klein","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2019111807384156900_B34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0065-2776(04)84006-9","article-title":"Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development.","volume":"84","author":"von Boehmer","year":"2004","journal-title":"Adv Immunol"},{"issue":"4","key":"2019111807384156900_B35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","article-title":"Toll-like receptors and innate immunity.","volume":"388","author":"Kumar","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2019111807384156900_B36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0198-8859(02)00780-2","article-title":"Specific stimulation of MHC-transgenic mouse T-cell hybridomas with xenogeneic APC.","volume":"64","author":"Vidovic","year":"2003","journal-title":"Hum Immunol"},{"issue":"2","key":"2019111807384156900_B37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0092-8674(94)90336-0","article-title":"MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.","volume":"76","author":"Germain","year":"1994","journal-title":"Cell"},{"issue":"11","key":"2019111807384156900_B38","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.4049\/jimmunol.0902313","article-title":"MHC drives TCR repertoire shaping, but not maturation, in recent thymic emigrants.","volume":"183","author":"Houston","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"2019111807384156900_B39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2516.2003.00780.x","article-title":"The epidemiology of inhibitors in haemophilia A: a systematic review.","volume":"9","author":"Wight","year":"2003","journal-title":"Haemophilia"},{"issue":"12","key":"2019111807384156900_B40","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1002\/jps.21765","article-title":"Effect of route of administration of human recombinant factor VIII on its immunogenicity in hemophilia A mice.","volume":"98","author":"Peng","year":"2009","journal-title":"J Pharm Sci"},{"key":"2019111807384156900_B41","doi-asserted-by":"crossref","first-page":"vi3","DOI":"10.1093\/ndt\/gfh1092","article-title":"Factors influencing the immunogenicity of therapeutic proteins.","volume":"20","author":"Schellekens","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"2019111807384156900_B42","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/j.1538-7836.2011.04472.x","article-title":"Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies.","volume":"9","author":"Aledort","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111807384156900_B43","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG Fc-derived peptide \u2018Tregitopes.\u2019","volume":"112","author":"de Groot","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111807384156900_B44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0001-2815.2004.00243.x","article-title":"Humanized animal models for autoimmune diseases.","volume":"63","author":"Gregersen","year":"2004","journal-title":"Tissue Antigens"},{"issue":"1","key":"2019111807384156900_B45","first-page":"105","article-title":"HLA transgenic mice as models of human autoimmune diseases.","volume":"2","author":"Das","year":"2000","journal-title":"Rev Immunogenet"},{"issue":"12","key":"2019111807384156900_B46","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.4049\/jimmunol.167.12.7119","article-title":"T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.","volume":"167","author":"Forsthuber","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"2019111807384156900_B47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0092-8674(93)90306-B","article-title":"Promiscuous and allele-specific anchors in HLA-DR-binding peptides.","volume":"74","author":"Hammer","year":"1993","journal-title":"Cell"},{"issue":"4","key":"2019111807384156900_B48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1055\/s-0037-1614081","article-title":"Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects.","volume":"84","author":"Reding","year":"2000","journal-title":"Thromb Haemost"},{"key":"2019111807384156900_B49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.bb.16.060187.001035","article-title":"The structural basis of antigen-antibody recognition.","volume":"16","author":"Mariuzza","year":"1987","journal-title":"Annu Rev Biophys Biophys Chem"},{"key":"2019111807384156900_B50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.iy.11.040193.002155","article-title":"The biochemistry and cell biology of antigen processing and presentation.","volume":"11","author":"Germain","year":"1993","journal-title":"Annu Rev Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/17\/4073\/1351690\/zh801712004073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/17\/4073\/1351690\/zh801712004073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T23:14:55Z","timestamp":1687302895000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/17\/4073\/29891\/CD4-Tcell-epitopes-associated-with-antibody"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,26]]},"references-count":50,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,4,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-08-374645","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,26]]}}}